What is 688505.SS's market cap?

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS) has a market capitalization of approximately $949.2 million, as of August 27, 2026, based on the most recent share price and shares outstanding.

Does 688505.SS pay a dividend?

Yes — Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS) pays a dividend annually, with a trailing-twelve-month yield of 0.36%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

Is 688505.SS profitable?

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

688505.SS

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.

SHH·Drug Manufacturers, Specialty & Generic · Healthcare

¥8.26¥0.06−0.72%

Market cap¥949.21M·Market closed·Aug 27 5:10 AM UTC

Price Chart

¥8.26−¥0.06 (−0.72%)today

−44.71%CAGR −11.18%

Select date range

FromTo

Jun 19, 2020Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)0.36%

Annual Dividend (FWD)¥0.03

Dividend Growth (5Y)—

Dividend Safety—

Payout Ratio—

FCF Payout Ratio21.7%

Most Recent Dividend¥0.030

Ex-Dividend DateJul 18

Payment DateJul 18

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateAug 15

Last Report DateSep 29

Reported vs Estimate−¥0.02

Earnings Surprise—

FinancialsFinancials Tab

Revenue¥667.94M

Net Income−¥126.26M

Net Margin−18.9%

Operating Cash Flow¥165.90M

Capital Expenditures¥22.82M

Free Cash Flow¥143.08M

Return on Equity−5.9%

Return on Invested Capital1.2%

Net Cash¥1.21B

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 688505.SS and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 688505.SS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 688505.SS and 80,000+ other tickers.

About Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., together with its associated entities, specializes in the research, development, production, and commercialization of cutting-edge biopharmaceutical products. The company's extensive pipeline is built upon several advanced technological platforms. Its genetic engineering platform prominently features antibody-drug conjugates (ADCs), with candidates like CD30-DM1 ADC and Trop2-SN38 ADC currently undergoing Phase I clinical trials for a range of tumors, including triple-negative breast, bladder, and gastric cancers. Additional ADCs, such…

CEO: Da Jun Zhao
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: SHH
Employees: 876
Website: www.fd-zj.com

Peers

Peers Tab

300391.SZ

Changjiang Pharmaceutical Group Co., Ltd.

Cap

¥66.6M

600200.SS

JiangSu WuZhong Pharmaceutical Development Co., Ltd.

Cap

¥206.2M

688329.SS

Suzhou Iron Technology CO.,LTD

Cap

¥1.7B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 688505.SS

What does Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. do?: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 688505.SS's market cap?: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS) has a market capitalization of approximately $949.2 million, as of August 27, 2026, based on the most recent share price and shares outstanding.
Does 688505.SS pay a dividend?: Yes — Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS) pays a dividend annually, with a trailing-twelve-month yield of 0.36%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.
Is 688505.SS profitable?: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.